{"id":"NCT00829413","sponsor":"Bracco Diagnostics, Inc","briefTitle":"SonoVue速-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization","officialTitle":"Characterization Of Focal Liver Lesions With Sonovue速-Enhanced Ultrasound Imaging: A Phase III, Intrapatient Comparative Study Versus Unenhanced Ultrasound Imaging Using Histology Or Combined Imaging/Clinical Data As Truth Standard","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-06","primaryCompletion":"2013-07","completion":"2013-07","firstPosted":"2009-01-27","resultsPosted":"2018-08-03","lastUpdate":"2018-08-03"},"enrollment":353,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Liver Neoplasms"],"interventions":[{"type":"DRUG","name":"SonoVue速","otherNames":["sulfur hexafluoride microbubbles"]}],"arms":[{"label":"Patients who received SonoVue","type":"OTHER"}],"summary":"The purpose of this study is to demonstrate the Sensitivity and Specificity of SonoVue速-enhanced ultrasound is superior to that of unenhanced ultrasound for the characterization of benign versus malignant FLLs using final diagnosis based on histology or combined imaging (CE-CT and/or CE MRI)/clinical data as truth standard.","primaryOutcome":{"measure":"Sensitivity: Percentage of True Positive Lesions Among All Malignant Lesions Per Truth Standard","timeFrame":"24 hours to 6 months","effectByArm":[{"arm":"Offsite Reader 1 UE-US","deltaMin":48.7,"sd":null},{"arm":"Offsite Reader 1 SonoVue CE-US","deltaMin":86.6,"sd":null},{"arm":"Offsite Reader 2 UE-US","deltaMin":35.3,"sd":null},{"arm":"Offsite Reader 2 SonoVue CE-US","deltaMin":75.6,"sd":null},{"arm":"Offsite Reader 3 UE-US","deltaMin":16,"sd":null},{"arm":"Offsite Reader 3 SonoVue CE-US","deltaMin":91.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<.0001"},{"comp":"OG002 vs OG003","p":"<.0001"},{"comp":"OG004 vs OG005","p":"<.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":12},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":340},"commonTop":["Nausea","Headache","Diarrhea","Flatulence","Dizziness"]}}